Building Resilience for the Future of Biopharma Innovation Read more →

After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? Read more →

AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytruda Read more →